Hoppa till innehållet

Redeye: Gapwaves - On the starting grid

Gapwaves' net sales and EBITDA, excluding ACI, surpassed Redeye Research estimates (RRe). Also, Hella has achieved the start of production (SOP), marking a significant milestone, although it is financially minor during the ramp-up period expected from 2024-2025. Gapwaves has prepared its organization for higher volumes and is strategically positioned with three signed tier-1 agreements and potentially a fourth. Despite these positive developments, Redeye calibrated its estimates, resulting in a lower fair value range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Source:MFN
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill du bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

spara
1180kr
Prenumerera